These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 100065)

  • 1. A/JAX inbred mice in chemotherapeutic investigations of experimental Chagas' disease.
    Gutteridge WE; Cover B; Gaborak M
    Ann Trop Med Parasitol; 1978 Aug; 72(4):329-38. PubMed ID: 100065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of SQ 18 506 with other nitroheterocyclic compounds on experimental Chagas' disease.
    Gutteridge WE; Gaborak M; Cover B
    Ann Trop Med Parasitol; 1978 Aug; 72(4):339-47. PubMed ID: 80977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection.
    Doyle PS; Zhou YM; Engel JC; McKerrow JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3932-9. PubMed ID: 17698625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of drug sensitivities of three strains of Trypanosoma cruzi in inbred A/Jax mice.
    Cover B; Gutteridge WE
    Trans R Soc Trop Med Hyg; 1981; 75(2):274-81. PubMed ID: 6795771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New process for screening of drugs in experimental infection with Trypanosoma cruzi].
    Campos R; Amato Neto V; de Souza HB; Braz LM
    Rev Inst Med Trop Sao Paulo; 1991; 33(4):325-7. PubMed ID: 1844956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Etiological treatment of Chagas' disease].
    Rassi A
    Arq Bras Cardiol; 1982 Apr; 38(4):277-81. PubMed ID: 6820273
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
    Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chagas' disease: a search for treatment and a question--should the disease be of military concern?
    Kinnamon KE; Poon BT; Scovill JP; Hanson WL; Waits VB
    Mil Med; 1997 Aug; 162(8):527-32. PubMed ID: 9271903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Chagas' disease].
    Apt W
    Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147
    [No Abstract]   [Full Text] [Related]  

  • 10. [Possibility of treatment in Chagas' disease].
    Prata A
    AMB Rev Assoc Med Bras; 1978 Apr; 24(4):140-2. PubMed ID: 98813
    [No Abstract]   [Full Text] [Related]  

  • 11. [Etiologic therapy of Chagas' disease].
    Boainain E; Rassi A
    Arq Bras Cardiol; 1979 Jun; 32(6):395-9. PubMed ID: 116629
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy of Chagas' disease.
    Gutteridge WE
    Trans R Soc Trop Med Hyg; 1976; 70(2):123-4. PubMed ID: 822539
    [No Abstract]   [Full Text] [Related]  

  • 13. Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment.
    Pereira-Chioccola VL; Fragata-Filho AA; Levy AM; Rodrigues MM; Schenkman S
    Clin Diagn Lab Immunol; 2003 Sep; 10(5):826-30. PubMed ID: 12965912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Chagas' disease in the mouse. IV. Effect of trypanocidal drugs.
    Laguens RP; Cabeza Meckert P; Chambó JG; Gelpi R
    Medicina (B Aires); 1983; 43(2):126-30. PubMed ID: 6420640
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
    Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
    Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined treatment of Chagas' disease with Bayer 2502 and corticoid (experimental and clinical study)].
    Andrade SG; Macêdo V
    Rev Inst Med Trop Sao Paulo; 1973; 15(6):421-30. PubMed ID: 4209018
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic efficacy of several nitroimidazoles for experimental Trypanosoma cruzi infections in mice.
    Malanga CM; Conroy J; Cuckler AC
    J Parasitol; 1981 Feb; 67(1):35-40. PubMed ID: 6785408
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chagas' disease: clastogenic effect of nifurtimox and benznidazole in children].
    Moya PR; Trombotto GT
    Medicina (B Aires); 1988; 48(5):487-91. PubMed ID: 3151216
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of immunosuppression and benzonidazole on Trypanosoma cruzi parasitism during experimental acute Chagas' disease.
    Okumura M; Mester M; Iriya K; Amato Neto V; Gama-Rodrigues J
    Transplant Proc; 1994 Jun; 26(3):1587-9. PubMed ID: 8030049
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment with low doses of aspirin during chronic phase of experimental Chagas' disease increases oesophageal nitrergic neuronal subpopulation in mice.
    Massocatto CL; Martins Moreira N; Muniz E; Marques de Araújo S; Pinge-Filho P; Rossi RM; de Almeida Araújo EJ; de Mello Gonçales Sant'ana D
    Int J Exp Pathol; 2017 Dec; 98(6):356-362. PubMed ID: 29349896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.